BiomX (NYSEAMERICAN:PHGE) Shares Up 9.9% – Time to Buy?

BiomX Inc. (NYSEAMERICAN:PHGE) shares rose 9.9% during mid-day trading on Thursday . The stock traded as high as $1.91 and last traded at $1.88. Approximately 70,220 shares traded hands during trading, a decline of 46% from the average daily volume of 130,091 shares. The stock had previously closed at $1.71.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their price objective on BiomX to $26.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $26.00.

BiomX Price Performance

The company has a market capitalization of $2.88 million, a P/E ratio of -0.07 and a beta of 1.56. The stock’s fifty day simple moving average is $6.93 and its 200-day simple moving average is $8.42.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).